Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00357825 · ClinicalTrials.gov registry record · Phase 2

A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia

A Phase 2 study of Pain, sponsored by Pfizer.

Completed
Registry status
Phase 2
Development phase
246
Enrollment target
20
Study locations

NCT00357825 is a Phase 2 study of Pain that has completed, run by Pfizer. The registered enrollment target is 246 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (19% lower). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00357825, a Phase 2 study of Pain, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 2
Development phase
246 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to assess the safety and effectiveness of \[S,S\]-Reboxetine in patients with fibromyalgia.

Conditions Studied

Pain

Interventions

  • DRUG [S,S]-Reboxetine

Study Locations (20)

Florida

  • Pfizer Investigational Site - DeLand
  • Pfizer Investigational Site - Ocala
  • Pfizer Investigational Site - Ocala
  • Pfizer Investigational Site - Tampa
  • Pfizer Investigational Site - Tampa
  • Pfizer Investigational Site - West Palm Beach

Arizona

  • Pfizer Investigational Site - Chandler
  • Pfizer Investigational Site - Phoenix
  • Pfizer Investigational Site - Phoenix
  • Pfizer Investigational Site - Sun City
  • Pfizer Investigational Site - Tucson

California

  • Pfizer Investigational Site - Auburn
  • Pfizer Investigational Site - Orangevale
  • Pfizer Investigational Site - Pismo Beach
  • Pfizer Investigational Site - Walnut Creek

Illinois

  • Pfizer Investigational Site - Gurnee
  • Pfizer Investigational Site - Moline

Delaware

  • Pfizer Investigational Site - Newark

Indiana

  • Pfizer Investigational Site - Indianapolis

Kansas

  • Pfizer Investigational Site - Pratt

Trial Details

FieldValue
Enrollment Target 246 participants
Start Date 2006-08
Est. Completion 2007-03
Phase Phase 2

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00357825

The ClinicalTrials.gov registry entry for NCT00357825 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (19% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which [S,S]-Reboxetine is the first listed.

NCT00357825 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Florida, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT00357825 about?

NCT00357825 is a clinical study titled "A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia". The purpose of this study is to assess the safety and effectiveness of \[S,S\]-Reboxetine in patients with fibromyalgia.

What is the current status of trial NCT00357825?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 246 participants. The study started on 2006-08. Estimated completion is 2007-03.

What conditions does trial NCT00357825 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT00357825?

The interventions under investigation include: [S,S]-Reboxetine (DRUG).

Who is sponsoring clinical trial NCT00357825?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00357825 being conducted?

This trial has 20 study locations across Arizona, California, Delaware, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.